Indore: A senior official of AAI Cargo Logistics and Allied Services Co Ltd (AAICLAS) on Wednesday said the work to deliver two crore doses of COVID-19 vaccine to 41 destinations across the country from Pune by January 8 is underway. On the sidelines of a programme here, AAICLAS Chief Operating Officer K Selvakumar told reporters … Read more
Mumbai | New Delhi: The government is yet to firm up its view on providing indemnity to Covid-19 vaccine makers against claims and lawsuits for damages in case of side effects. “During the usual vaccination drive, it is the responsibility of the company to provide protection in case of any untoward incident. While we are … Read more
Terming the vaccination of about 70 lakh health workers as the first wave of the first phase of vaccination drive, Dr Paul said that it would be easier to vaccinate health workers as they are already present at the healthcare facilities. After the Drug Controller General of India (DGCI) approved the emergency use of two … Read more
COVID-19 Coronavirus Vaccine: As per the production targets, Adar Poonawalla said SII will be producing around 300 million doses of Covishield by July 2021. (Reuters image/ Representational Photo) Covid-19 vaccination drive: Adar Poonawalla, chief executive officer of vaccine-maker Serum Institute of India (SII), said on Monday that his firm was ready with a stockpile of … Read more
The complainant also demanded that the ongoing trials in India of the vaccine candidate be immediately halted. Vaccine major Serum Institute of India (SII) on Sunday strongly refuted an allegation that Covishield, the vaccine candidate for Covid-19, which is in the third phase of human trials in India, triggered adverse reaction in a Chennai-based 40-year-old … Read more
AstraZeneca said it will immediately prepare regulatory submission of the data to authorities around the world that have a framework in place for conditional or early approval. Even as AstraZeneca on Monday announced interim results of clinical trials for the Covid-19 vaccine saying it was 70% effective on average, Serum Institute of India (SII) indicated … Read more
A volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa’s first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. (AP photo/FILE) The University of Oxford and Britain’s AstraZeneca announced on Monday that the Covid-19 … Read more
India will have 200 to 300 million Covid-19 vaccine doses ready by the December-end and the final tested vaccine will be available by March 2021, Serum Institute’s (SII) Executive Director Dr Suresh Jadhav said on Saturday. “India will have 200 to 300 million Covid vaccine doses ready by the end of December. So, once the … Read more